SI-BONE Inc
For the period ended Dec 31, 2023. Filed Feb 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information Item 9C
During the fiscal quarter ended December 31, 2023, the following Section 16 officer and director adopted, modified orterminated a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act) as set forth in the table below.
| Type of Trading Arrangement | |||||
|---|---|---|---|---|---|
| Name of Position · Action · Adoption/Termination Date · Rule 10b5-1* · Non-Rule 10b5-1** · Total Shares of Common Stock to be Sold · Total Shares of Common Stock to be Purchased · Expiration Date | |||||
| Jeffrey W. Dunn, Chairman | Adoption | November 8, 2023 | X | 262,239 | May 15, 2025 |
| Anthony Recupero, President of Commercial Operations | Adoption | December 13, 2023 | X | 12,687 | December 31, 2024 |
| *Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act | |||||
| ** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. | |||||
None of the Company’s other directors or executive officers adopted a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, as defined in Item 408 of Regulation S-K under the Exchange Act during the three-month period ended December 31, 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.